Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$28.02 +0.16 (+0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

Acadia Pharmaceuticals (ACAD) Prepaid Assets (2010 - 2026)

Acadia Pharmaceuticals (ACAD) posted quarterly Prepaid Assets of $64.6 million for Q1 2026, up 22.57% year-over-year from $52.7 million in Q1 2025, and up 8.52% quarter-over-quarter from $59.5 million in Q4 2025.

Analysis

Acadia Pharmaceuticals (ACAD) Prepaid Assets (2010 - 2026) Analysis & Trends

Acadia Pharmaceuticals' Prepaid Assets history runs 17 years deep, the most recent figure standing at $64.6 million for Q1 2026.

  • In Q1 2026, Prepaid Assets rose 22.57% year-over-year to $64.6 million; the TTM figure through Mar 2026 stood at $64.6 million (up 22.57% YoY), while the FY2025 annual figure was $59.5 million, up 6.91% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $64.6 million, up from $59.5 million in the prior quarter.
  • The five-year high for Prepaid Assets was $64.6 million in Q1 2026, with the low at $21.0 million in Q2 2022.
  • The 5-year median for Prepaid Assets is $42.8 million (2024), against an average of $41.3 million.
  • The sharpest annual moves came in 2022 and 2024: Prepaid Assets slipped 20.05% in 2022, then surged 92.74% in 2024.
  • Acadia Pharmaceuticals' Prepaid Assets stood at $21.4 million in 2022, then jumped by 82.69% to $39.1 million in 2023, then soared by 42.44% to $55.7 million in 2024, then gained by 6.91% to $59.5 million in 2025, then rose by 8.52% to $64.6 million in 2026.
  • Business Quant data shows ACAD's Prepaid Assets at $64.6 million in Q1 2026, $59.5 million in Q4 2025, and $60.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Acadia Pharmaceuticals 4.82 Bn 3.86 Bn 279.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 69.37 Mn
Mar 31, 2026 64.60 Mn
Dec 31, 2025 59.53 Mn
Sep 30, 2025 60.87 Mn
Jun 30, 2025 52.75 Mn
Mar 31, 2025 52.70 Mn
Dec 31, 2024 55.68 Mn
Sep 30, 2024 51.55 Mn
Jun 30, 2024 46.06 Mn
Mar 31, 2024 42.76 Mn
Dec 31, 2023 39.09 Mn
Sep 30, 2023 37.95 Mn
Jun 30, 2023 23.90 Mn
Mar 31, 2023 23.63 Mn
Dec 31, 2022 21.40 Mn
Sep 30, 2022 22.99 Mn
Jun 30, 2022 20.95 Mn
Mar 31, 2022 25.76 Mn
Dec 31, 2021 23.89 Mn
Sep 30, 2021 24.62 Mn